Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III.
Kaufmann P, Thompson JL, Levy G, Buchsbaum R, Shefner J, Krivickas LS, Katz J, Rollins Y, Barohn RJ, Jackson CE, Tiryaki E, Lomen-Hoerth C, Armon C, Tandan R, Rudnicki SA, Rezania K, Sufit R, Pestronk A, Novella SP, Heiman-Patterson T, Kasarskis EJ, Pioro EP, Montes J, Arbing R, Vecchio D, Barsdorf A, Mitsumoto H, Levin B; QALS Study Group. Kaufmann P, et al. Among authors: barsdorf a. Ann Neurol. 2009 Aug;66(2):235-44. doi: 10.1002/ana.21743. Ann Neurol. 2009. PMID: 19743457 Free PMC article. Clinical Trial.
Web-based data management for a phase II clinical trial in ALS.
Buchsbaum R, Kaufmann P, Barsdorf AI, Arbing R, Montes J, Thompson JL; QALS Study Group. Buchsbaum R, et al. Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):374-7. doi: 10.3109/17482960802378998. Amyotroph Lateral Scler. 2009. PMID: 19922127 Free PMC article.
A two-stage design for a phase II clinical trial of coenzyme Q10 in ALS.
Levy G, Kaufmann P, Buchsbaum R, Montes J, Barsdorf A, Arbing R, Battista V, Zhou X, Mitsumoto H, Levin B, Thompson JL. Levy G, et al. Among authors: barsdorf a. Neurology. 2006 Mar 14;66(5):660-3. doi: 10.1212/01.wnl.0000201182.60750.66. Neurology. 2006. PMID: 16534103 Clinical Trial.
Patient preferences in the treatment of diabetic retinopathy.
Wirostko B, Beusterien K, Grinspan J, Ciulla T, Gonder J, Barsdorf A, Pleil A. Wirostko B, et al. Among authors: barsdorf a. Patient Prefer Adherence. 2011;5:229-37. doi: 10.2147/PPA.S11972. Epub 2011 May 24. Patient Prefer Adherence. 2011. PMID: 21660105 Free PMC article.
Patient preferences for diabetic retinopathy health States.
Szabo SM, Beusterien KM, Pleil AM, Wirostko B, Potter MJ, Tildesley H, Gonder J, Barsdorf A, Levy AR. Szabo SM, et al. Among authors: barsdorf a. Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3387-94. doi: 10.1167/iovs.09-4194. Epub 2010 Jan 6. Invest Ophthalmol Vis Sci. 2010. PMID: 20053977
Best Practice Recommendations: User Acceptance Testing for Systems Designed to Collect Clinical Outcome Assessment Data Electronically.
Gordon S, Crager J, Howry C, Barsdorf AI, Cohen J, Crescioni M, Dahya B, Delong P, Knaus C, Reasner DS, Vallow S, Zarzar K, Eremenco S; Electronic Patient-Reported (ePRO) Consortium, PRO Consortium. Gordon S, et al. Among authors: barsdorf ai. Ther Innov Regul Sci. 2022 May;56(3):442-453. doi: 10.1007/s43441-021-00363-z. Epub 2022 Mar 1. Ther Innov Regul Sci. 2022. PMID: 35233726 Free PMC article.
27 results